Aala Dweik,Hadeel Dweik,Hira Mian et al.
Aala Dweik et al.
Gender disparities exist in academia and are disproportionately affecting females. We conducted a cross-sectional study to analyze gender disparities in multiple myeloma (MM) publications. A total of 679 publications with 8898 authorships w...
Myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA presenting as myeloid sarcoma [0.03%]
PDGFRA重排伴嗜酸粒细胞增多的髓系/淋巴系肿瘤以髓系白血病肉瘤样病变 Presentation
Mohammad Barouqa,Dragan Jevremovic,Patricia Theresa Greipp et al.
Mohammad Barouqa et al.
Point of care testing to monitor INR control in patients with antiphospholipid syndrome [0.03%]
抗磷脂综合征患者的凝血酶原时间国际标准化比值的点彩式监测
Michael Masucci,Annabelle Li Kam Wa,Emilia Shingleton et al.
Michael Masucci et al.
Patients with antiphospholipid syndrome (APS) typically require lifelong warfarin anticoagulation following a thrombotic event due to a significant risk of recurrent thrombosis. Point of care testing (POCT) to monitor INR is discouraged in ...
Silvia Escribano Serrat,Javier Cucharero Martín,Fiorella Medina Salazar et al.
Silvia Escribano Serrat et al.
A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinib [0.03%]
伊布替尼治疗后进展的华氏巨球蛋白血症患者中达沙替尼治疗的初步研究
Jorge J Castillo,Shayna Sarosiek,Catherine A Flynn et al.
Jorge J Castillo et al.
The hematopoietic cell kinase (HCK) regulates BTK activation and represents a potential therapeutic target in Waldenstrom macroglobulinemia (WM). We investigated dasatinib, a potent HCK inhibitor, in patients with WM progressing on ibrutini...
Miles Kiernan,Hanna Renshaw,Danny Mitry et al.
Miles Kiernan et al.
Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report [0.03%]
获得性第7因子抑制物与原发中枢神经系统淋巴瘤相关的病例报告
Vanshika Goyal,Giselle Salmasi,Andrew D Leavitt et al.
Vanshika Goyal et al.
Paraneoplastic coagulopathies are uncommon in patients with lymphoma. We report the first case of an acquired coagulopathy in a patient with isolated primary central nervous system lymphoma (PCNSL) demonstrating large-cell histology. In our...
Case Reports
EJHaem. 2022 Jun 7;3(3):1000-1002. DOI:10.1002/jha2.482 2022
Acute lymphoblastic leukemia with clonal evolution due to delay in chemotherapy: A report of a case [0.03%]
化疗延迟所致急性淋巴细胞白血病克隆演化1例报告
Ahmed Maseh Haidary,Ramin Saadaat,Jamshid Abdul-Ghafar et al.
Ahmed Maseh Haidary et al.
Clonal evolution in acute leukemias is one of the most important factors that leads to therapeutic failure and disease relapse. Delay in therapeutic intervention is one of the reasons that leads toward clonal evolution. In this report, we p...
Case Reports
EJHaem. 2022 Jun 7;3(3):1013-1017. DOI:10.1002/jha2.483 2022
Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children [0.03%]
预防性和治疗性使用defibrotide对造血干细胞移植后儿童发生Sinusoidal Obstruction Syndrome及其严重程度的影响研究
Carl J Rudebeck,Cécile Renard,Carine Halfon-Domenech et al.
Carl J Rudebeck et al.
Defibrotide (DF) is indicated for the treatment of severe sinusoidal obstruction syndrome (SOS) following hematopoietic stem cell transplantation (HSCT), but its prophylactic use against SOS is not recommended yet. This study describes the ...
Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphoma [0.03%]
低淋巴细胞/单核细胞比率预测高危侵袭性大B细胞淋巴瘤预后不良
Heli Vajavaara,Suvi-Katri Leivonen,Judit Jørgensen et al.
Heli Vajavaara et al.
Low lymphocyte-to-monocyte-ratio (LMR) has been associated with unfavorable survival in patients with diffuse large B-cell lymphoma (DLBCL). To date, however, the impact of LMR on survival has not been examined in a uniformly treated cohort...